The Accuracy of Modified Risk Malignancy Index (RMI) in Predicting Malignancy of Epithelial Type Ovarian Cancer: Akurasi Modifikasi Risk of Malignancy Index dalam Memprediksi Keganasan Tumor Ovarium  Tipe Epitel by Triana, Esfi et al.
The Accuracy of Modifi ed Risk of Malignancy Index (RMI) in Predicting 
Malignancy of Epithelial Type Ovarian Tumor
Akurasi Modifi kasi Risk of Malignancy Index dalam Memprediksi 
Keganasan Tumor Ovarium Tipe Epitel
Esfi  Triana, Defrin, Joserizal Serudji, Adriswan
Vol 7, No 3 
July 2019
Department of Obstetrics and Gynecology
Faculty of Medicine Universitas Andalas/Dr. M. Djamil General Hospital
Padang
Correspondence author: Esfi  Triana. esfi triana@gmail.com
Research Article
The Accuracy of Modifi ed Risk 228
Abstract
Objective : To investigate the accuracy of modifi ed Risk 
of Malignancy Index (RMI) in predicting malignancy of 
epithelial type ovarian tumour.
Methods : This research was comparative research 
using cross-sectional study design, which compared RMI 
modifi cation and RMI method in predicting malignancy 
of epithelial type ovarian tumour. The sampling technique 
was consecutive sampling. This research was conducted on 
October 2017 until samples were fulfi lled in Obstetrics and 
Gynecology Division of RSUP Dr. M. Djamil and Laboratory 
of RSUP Dr. M Djamil in Padang. Chi-square test was used 
to compare specifi city, sensitivity, positive predictive value 
(PPV), negative predictive value (NPV), positive likelihood 
ratio (PLR), negative likelihood ratio (NLR, and accuracy of 
RMI modifi cation and RMI with 95% CI (p≤0,05).
Results : A total of 61 subjects were recruited in this study. 
Sensitivity, specifi city, PPV, NPV, PLR, NLR, and accuracy RMI 
modifi cation scoring was 90.5%, 82.5%, 73.1%, 94.3%, 5.1, 
0.1, dan 85.2%. Sensitivity, specifi city, PPV, NPV, PLR, NLR, 
and accuracy RMI scoring was 66.7%, 70%, 53.8%, 80%, 2.2, 
0.4, and 70%.
Conclusions : Modifi ed RMI scoring method was more 
accurate in predicting the malignancy of ovarian type 
epithelial tumours than RMI.
Keywords : CA125, malignancy, ovarian tumor,pelvic mass, 
RMI.
Abstrak
Tujuan : Mengetahui akurasi Risk of Malignancy Index (RMI) 
dalam prediksi keganasan tumor ovarium tipe epitel.
Metode : Penelitian ini merupakan penelitian komparatif 
dengan desain penelitian potong lintang yang 
membandingkan metode RMI modifi kasi dan RMI dalam 
prediksi keganasan tumor ovarium tipe epitel. Jumlah 
sampel sebanyak 61 orang. Teknik pengambilan sampel 
berurutan. Penelitian di mulai pada bulan Oktober 2017 
hingga jumlah sampel terpenuhi di Departemen Obstetri 
dan Ginekologi RSUP Dr. M Djamil dan Laboratorium RSUP 
Dr. M Djamil Padang. Untuk membandingkan spesifi sitas, 
sensitivitas, nilai duga positif (NDP), nilai duga negatif (NDN), 
rasio kemungkinan positif (RKP), rasio kemungkinan negatif 
(RKN), dan akurasi RMI modifi kasi dan RMI digunakan uji 
chi-square dengan 99% CI (p≤0,01).
Hasil : Sensitivitas, spesifi sitas, NDP, NDN, RKP, RKN, dan 
akurasi skoring RMI modifi kasi adalah 90,5%, 82,5%, 73,1%, 
94,3%, 5,1, 0,1, dan 85,2%. Sensitivitas, spesifi sitas, NDP, 
NDN, RKP, RKN, dan akurasi skoring RMI adalah 66,7%, 70%, 
53,8%, 80%, 2,2, 0,4, dan 70%. 
Kesimpulan : Metode skoring RMI modifi kasi lebih akurat 
dalam memprediksi keganasan tumor ovarium tipe epitel 
dibandingkan RMI.
Kata kunci : CA125, keganasan, massa pelvik, RMI, tumor 
ovarium.
INTRODUCTION
Ovarian cancer is the third most cancer in 
women in Indonesia, which is 4.27 cases per 
100000 women.1As the second most common 
gynaecological cancer in the world, most are 
epithelial types.2The absence of screening 
methods causes ovarian cancer is often diagnosed 
when the patient has a complaint or is already 
at an advanced stage. This brings diffi culties 
and complexity in managing, which leads to 
a worse prognosis.3Management effi ciency in 
patients with ovarian cancer can be improved by 
standardizing preoperative evaluations.
Many women with advanced ovarian cancer 
undergo primary suboptimal surgery in regional 
hospitals. The amount of tumour tissue remaining 
after primary cytoreductive surgery is one of the 
most important prognostic factors of ovarian 
cancer. The type of surgery also the experience of 
a doctor who performs surgery is another major 
factor affecting the prognosis. Therefore, proper 
preoperative diagnosis is very crucial and is still 
a challenge for gynaecologists. This temporary 
diagnosis is useful in referring patients who 
are appropriate to an oncology specialist and 
also useful in planning appropriate operative 
management. The increase in morbidity and 
mortality rates due to the unnecessary laparotomy 
performed to fi nd early-stage ovarian cancer is a 
clinical dilemma.4
Ultrasound is a standard diagnostic test to 
evaluate pelvic masses. Ultrasound is not invasive, 
inexpensive, readily available and free of ionizing 
radiation. Whether ultrasound can be used to 
distinguish benign and malignant masses has 
been the subject of many studies. The principles 
of ultrasound include confi rming the presence 
of a mass, differentiating ovarian mass from 
the mass originating from the tube or uterus, 
describing the internal appearance of the mass 
and fi nding other abnormal appearance. It may 
be possible to establish a malignancy based on 
ultrasound appearance, but a defi nite diagnosis 
cannot always be made. Ultrasound has a high 
specifi city of 97.7% and a positive predictive 
value of only 1.5%.5
CA125 marker tumour has been tested for 
their ability to distinguish malignant and benign 
pelvic masses. Serum CA125 elevation often 
precedes clinical manifestations or ultrasound 
detection from residual diseases in 3-6 months. 
Although the single value of CA125 alone is 
not suffi ciently specifi c and sensitive as initial 
detection, its specifi city increases with periodic 
CA125 measurements and is combined with 
ultrasound.5
In 1990 introduced the risk of malignancy 
index (RMI), which is the fi rst diagnostic model 
that combines demographic, sonographic and 
biochemical parameters to investigate patients 
with adnexa in mass. The RMI was fi rst modifi ed 
by Tingulstad et al in 1996 (RMI2) and the 
second time in 1999 (RMI3). These three versions 
of RMI are assessed in many prospective and 
retrospective clinical studies. Even made RMI 4, 
but the validity still needs to be confi rmed in 
future studies. The difference between these three 
RMIs is in the difference in USG fi nding scores 
and menopausal status. These three RMIs were 
tested, with evidence of criteria for malignancy 
on ultrasound, such as liver metastases or distant 
metastases and they found that RMI2 had a better 
performance in detecting ovarian malignancies. 
The value of RMI 200 has proven to be the best 
limit for distinguishing benign and malignant 
adnexal masses, with a high degree of sensitivity 
and specifi city (51% -90% and 51% -97%).6
The International Ovarian Tumor Analysis 
(IOTA) group in 2008 had a similar system, the 
USG Simple Rules (SR). SR classifi ed the tumour 
into benign, malignant and indeterminate. SR 
sensitivity 92%, and specifi city 96%.7
IOTA SR is not an ovarian cancer screening 
method but is the best predictor test in the 
preoperative classifi cation of an adnexal tumour. 
IOTA SR is simple, easy to apply, and has been 
validated in many reports and should be widely 
used in everyday medical practice.8
One of the goals of IOTA is to establish a 
method for predicting ovarian malignancy that 
can make ultrasound examiners who are less 
experienced resemble USG results performed 
by an experienced expert. The IOTA method 
has shown a better performance than RMI if an 
ultrasound examination is performed by a person 
who is less experienced. Recent evidence was 
conducted on 124 women, where SR had a good 
performance test even though it was performed 
by a less experienced examiner. If these results 
persist, then an ultrasound-based prediction 
method such as SR can offer a better performance 
test compared to biomarkers such as CA 125 and 
HE4 to classify ovarian abnormalities, especially 
when performed on premenopausal women.8
SR has been well received by clinicians, and the 
Royal College of Obstetricians and Gynecologists 
(RCOG) have included SR in their top green 
guidelines for assessing and managing ovarian 
mass in premenopausal patients.9
Researchers predict that by including the 
IOTA scoring system into RMI, the specifi city and 
sensitivity of RMI can be signifi cantly improved. It 
is against this background that the author wants 
to investigate the accuracy of RMI that has been 
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modifi ed by including IOTA SR in predicting the 
malignancy of epithelial type ovarian tumours.
METHODS
This study was comparative research with 
cross-sectionalstudy design, which compares 
RMI modifi cation and RMI method to predict 
malignancy of epithelial type ovarium tumour.
The study was conducted from October 2017 
until the number of samples was met at Obstetric 
and Gynecology Division of RSUP Dr. M. Djamil 
and Laboratory of RSUP Dr. M Djamil in Padang.
The population of this study were patients 
with a diagnosis of ovarian tumour which would 
be planned for surgery at RSUP Dr. M. Djamil with 
the inclusion criteria had never been diagnosed 
with ovarian cancer before and was willing to 
be a research sample. Sampling technique was 
consecutive sampling. Each sample will be 
explained about information for consent and 
sign an informed consent.
Chi-square test was used to determine 
specifi city, sensitivity, positive predictive value 
(PPV), negative predictive value (NPV), positive 
likelihood ratio (PLR), negative likelihood ratio 
(NLR), and accuracy with 99% CI (p≤0,01). Data 
were analyzed by a computer program.
RESULTS
Table 1. Characteristics of Research Subject
Characteristic
Pathological Anatomy 
Malign (%) Benign (%)
P-value
Menopausal Status
Yes
No
Ultrasound score
3
1
IOTA
3
1
CA125 level
≥ 35
< 35
10 (50)
11 (26.8)
12 (36.4)
9 (32.1)
21 (100)
0 (0)
20 (54.1)
1 (4.2)
10 (50)
30 (73.2)
21 (63.6)
19 (67.9)
0 (0)
40 (100)
17 (45.9)
23 (95.8)
0.1
0.9
0.0001
0.0001
Based on Table 1 it is known that menopausal 
status and ultrasound score were not associated 
with ovarian cystic mass (p>0,01), whereas IOTA 
and CA125 level had a signifi cant relationship 
with ovarian cystic mass (p<0,01).  
Sensitivity, specifi city, PPV, NPV, PLR, NLR, and 
accuracy of RMI modifi cation are 90.5%, 82.5%, 
73.1%, 94.3%, 5.1, 0.1, and 85.2%, respectively.
Sensitivity, specifi city, PPV, NPV, PLR, NLR, and 
accuracy of RMI are 66.7%, 70%, 53.8%, 80%, 2.2, 
0.4, and 70%, respectively.
To fi nd out more accurate scoring method, 
an analysis was carried out comparing the 
accuracy of RMI modifi cation and RMI to 
predict the malignancy of epithelial type 
ovarian tumour with the following result:
Table 2. Table 2 x 2 RMI Modifi kasi
Table 3. Table 2 x 2 RMI 
RMI 
Modifi kasi
RMI 
Modifi kasi
Pathological Anatomy 
Pathological Anatomy 
Malign
Malign
Benign
Benign
Total
Total
≥ 200
< 200
Total
≥ 200
< 200
Total
Sensitivity
Specifi city PPV
NPV
PLR
NLR
Accuracy
Sensitivity
Specifi city PPV
NPV
PLR
NLR
Accuracy
a/(a+c) x 100% = 19/21 x 100% = 90.5%
d/(b+d) x 100% = 33/40 x 100% = 82.5%
a/(a+b) x 100% = 19/26 x 100% = 73.1%
d/(c+d) x 100% = 33/35 x 100% = 94.3%
{a/(a+c) : b/(b+d)} = 0,9/0,175 = 5.1
{c/(a+c) : d/(b+d)} = 0,1/0,8 = 0.1 
a+d / (a+b+c+d) x 100% = 52/61 x 100% = 85.2%
a/(a+c) x 100% = 14/21 x 100% = 66.7%
d/(b+d) x 100% = 28/40 x 100% = 70%
a/(a+b) x 100% = 14/26 x 100% = 53.8%
d/(c+d) x 100% = 28/35 x 100% = 80%
{a/(a+c) : b/(b+d)} = 0,67/0,3 = 2.2
{c/(a+c) : d/(b+d)} = 0,3/0,7 = 0.4
a+d / (a+b+c+d) x 100% = 42/61 x 100% = 70%
=
=
=
=
=
=
=
=
=
=
=
=
=
=
19 
2 
21
14
7
21
7 
33 
40 
12
28 
40
26
35
61
26
35
61
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Table 4. Comparison of RMI Modifi cation and RMI Diagnostic Values
Scoring
method
Sensitivity
(%)
Specifi city
(%)
PPV
(%)
NPV
(%)
PLR NLR Accuracy
(%)
Chi-square (p)
Kappa (R)
RMI
RMI modifi cation
66.7
90.5
70
82.5
53.8
73.1
80
94.3
2.2
5.1
0.4
0.1
70
85.2
0.01
0.35
0.0001
0.69
There was a signifi cant relationship between 
ovarian tumour with RMI modifi cation and RMI 
(p ≤ 0,01) (Table 4). The result of the suitability 
analysis showed that the kappa values was 0.69 
in the modifi ed RMI and 0.35 in the RMI.
DISCUSSION
Based on the results of the study, it was found 
that Ca125 levels and ultrasound examination 
with the SR IOTA approach were associated with 
ovarian malignancy, while menopausal status and 
ultrasound examination with a pattern recognition 
approach did not have a signifi cant relationship 
with ovarian malignancy. The results of Akturk et 
al (2011) found that Ca125 levels, menopausal 
status, and ultrasound examination with a pattern 
recognition approach had a signifi cant association 
with ovarian tumour malignancy (p <0.001).10 
Likewise with research conducted where there 
was a relationship between menopausal status, 
ultrasound examination with pattern recognition 
approach, and serum Ca125 with ovarian tumour 
malignancy (p = 0.0001.11, 12
In this study, a new scoring modifi ed the 
RMI by replacing the ultrasound examination 
approach from the pattern recognition approach 
with the SR IOTA. The results of the analysis 
showed that the sensitivity of the modifi ed RMI 
diagnostic test was higher at 90.5% while the RMI 
was 66.7%. This means that 90.5% of patients with 
malignant ovarian tumours will be detected with 
modifi ed RMI scoring while in RMI scoring 66.7% 
of patients. Modifi cation of RMI specifi city was 
also obtained higher at 82.5% and RMI 70%. This 
shows that 82.5% of patients with benign ovarian 
tumours will give negative diagnostic tests on 
modifi ed RMI scoring while RMI 70% of patients.
Modifi ed RMI scoring method shows PPV and 
NPV are 73.1% and 94.3% which means that the 
probability of a person suffering from malignant 
ovarian tumours is 73.1% and the probability of 
someone not suffering from malignant ovarian 
tumours is 94.3%. PPV and NPV values using the 
modifi ed RMI scoring method are higher than 
RMI.
The accuracy of the modifi ed RMI scoring 
method is higher than the RMI of 85.2%. This 
means that the modifi ed RMI diagnostic test 
provides more accurate results compared to the 
RMI method. The results showed that sensitivity, 
specifi city, PPV, NPV, PLR, and modifi ed RMI 
accuracy were higher than RMI. Statistical 
tests showed both scorings could be used in 
predicting ovarian tumour malignancy (p≤0.01), 
and kappa values on RMI and RMI modifi cation 
were 0.35 and 0.69 which means modifi ed RMI 
was better than RMI in predicting ovarian tumour 
malignancy.
In addition, several studies regarding RMI 
scoring have been carried out. All research that 
has been done shows that RMI can be used to 
predict ovarian malignancy before surgery with 
a value of p <0.01 with various sensitivity values, 
specifi city, PPV, NPV, PLR, NLR, and accuracy.
According to some previous studies, the 
IOTA SR has high sensitivity and specifi city. 
Timmerman's research was delivered in 2010 
with a sensitivity and specifi city of 92% and 
96%.13Likewise in a study with a sensitivity and 
specifi city of 87% and 98% and which conducted 
an external study of one fl ashlight validation 
on 122 ovarian tumors within 4 years with the 
results of sensitivity and specifi city of 73% and 
97%. However, they did not evaluate the strategy 
if the IOTA SR found inconclusive results.14Ideally, 
patients with inconclusive IOTA SR results should 
be referred to a gynaecological ultrasound expert 
for further assessment15.However, for ultrasound 
examiners who fi nd it inconclusive at IOTA SR 
should classify it into malignancy if there is no 
gynaecological ultrasound expert. According to 
Bernardin if there is no experienced ultrasound 
examiner available, another alternative is to do 
MRI in patients.16However, further research is 
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needed for this protocol.
Another study, published in the year, was 
conducted on 2403 samples by comparing 
ADNEX models with CA125 and without CA 125, 
IOTA SR and RMI. Produces similar specifi city of 
80%, but with different levels of sensitivity, namely 
for ADNEX and SR IOTA between 92.3 - 93.0% 
compared to only 81.7% of RMI. This shows that 
the ADNEX and IOTA SR models have a better 
ability to predict malignancy than RMI.17In this 
study, it was found that the modifi ed RMI scoring 
by replacing the pattern recognition ultrasound 
variable with IOTA SR ultrasound can be used 
in predicting ovarian malignancy with a p-value 
<0.01. If the modifi ed RMI is compared to RMI, 
it is seen that the RMI modifi cation is better than 
RMI. So that modifi ed RMI can be used as a new 
score for predicting ovarian malignancy before 
surgery.
CONCLUSION
Sensitivity, specifi city, positive predictive value 
(PPV), negative predictive value (NPV), positive 
likelihood ratio (PLR), negative likelihood ratio 
(NLR), and accuracy of RMI modifi cation scoring 
are 90.5%, 82.5%, 73.1%, 94.3%, 5.1, 0.1, and 
85.2%, respectively. Sensitivity, specifi city, PPV, 
NPV, PLR, NLR, and accuracy of RMI scoring are 
66.7%, 70%, 53.8%, 80%, 2.2, 0.4, 0.7, and 70%, 
respectively. RMI modifi cation scoring method 
are more accurate to predict malignancy of 
epithelial type ovarian tumour than RMI.
We recommend that the pattern recognition 
ultrasound examination for comparison be done 
by the same and qualifi ed people. For further 
research, it is expected that the inclusive value in 
IOTA will be included in malignancy to increase 
the sensitivity value.
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